Physician profile
Andra H James
NPI 1245314301
$39,683.93
in general payments reported to CMS, 2019-2025
10 companies · $2,383 in 2025
The $2,383 reported for 2025 was more than what 94% of Maternal & Fetal Medicine providers received nationally (typical 2025 total: $55.21).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,104 · 2021: $9,352 · 2022: $6,393 · 2023: $5,258 · 2024: $9,193 · 2025: $2,383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $8,283 · Consulting Fee: $3,400 · Travel and Lodging: $2,871 · Food and Beverage: $1,871 · Gift: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $8,283.00 |
| Consulting Fee | $3,400.00 |
| Travel and Lodging | $2,870.97 |
| Food and Beverage | $1,870.54 |
| Gift | $410.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerus Corporation | $22,565.60 | 2021-2025 | Intercept Blood System For Cryoprecipitation, Intercept Blood System For Platelets |
| Octapharma USA, INC. | $7,552.02 | 2021 | |
| American Regent | $7,085.51 | 2019 | |
| Hemosonics LLC | $1,000.00 | 2022 | |
| Diagnostica Stago Sas | $583.00 | 2025 | |
| Novo Nordisk INC | $440.00 | 2022 | |
| Sobi, INC | $203.37 | 2023-2024 | |
| Genzyme Corporation | $130.63 | 2022-2023 | |
| Biomarin Pharmaceutical INC. | $105.34 | 2023 | Roctavian |
| Abbott Laboratories | $18.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andra James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.